Through the 90-day period concluding February 19, 2026, Glucotrack's top three insider stakeholders include Director Andrew K Balo (75 shares), Director Drew Sycoff (0 shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Drew Sycoff | 0 | 24 Apr, 2024 | |
| Andrew K Balo | 75 | 28 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Mar, 2025 | Andrew K Balo | Common Stock, par value $0.001 per share | A | 4,490 | $0.00 | 75 | D | A |
| 22 Apr, 2024 | Drew Sycoff | Common Stock | A | 182,540 | $1.26 | 0 | D | P |
| 22 Apr, 2024 | Drew Sycoff | - | - | 0 | D | |||
| 20 Mar, 2017 | Angela Strand Boydston | Common Stock, par value $0.001 per share | A | 4,445 | $0.00 | 0 | D | A |
| 20 Mar, 2017 | Angela Strand Boydston | Common Stock, par value $0.001 per share | A | 13,334 | $0.00 | 0 | I | A |
| 20 Mar, 2017 | Angela Strand Boydston | - | - | 0 | D | |||
| 20 Mar, 2017 | Leslie Seff | - | - | 0 | D | |||
| 20 Mar, 2017 | Leslie Seff | Common Stock, par value $0.001 per share | A | 3,334 | $0.00 | 0 | D | A |
| 11 Mar, 2015 | Avner Gal | Common Stock, par value $0.001 per share | D | 136,162 | $0.00 | 0 | I | J |
| 11 Mar, 2015 | Zvi Cohen | Common Stock, par value $0.001 per share | D | 120,077 | $0.00 | 0 | I | J |
| 11 Mar, 2015 | David Malka | Common Stock, par value $0.001 per share | D | 61,471 | $0.00 | 0 | I | J |
| 11 Mar, 2015 | David Malka | - | - | 0 | I |